Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human vaccines & …, 2016 - Taylor & Francis
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human …, 2016 - … .esploro.exlibrisgroup.com
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human vaccines & …, 2016 - pubmed.ncbi.nlm.nih.gov
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
[引用][C] Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human Vaccines & …, 2015 - cir.nii.ac.jp
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML][HTML] Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human Vaccines & …, 2016 - ncbi.nlm.nih.gov
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.
N Gaborit, M Lindzen, Y Yarden - Human Vaccines & …, 2015 - europepmc.org
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
[PDF][PDF] Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - 2015 - researchgate.net
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human …, 2016 - weizmann.esploro.exlibrisgroup.com
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
N Gaborit, M Lindzen, Y Yarden - Human …, 2016 - … .esploro.exlibrisgroup.com
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.
N Gaborit, M Lindzen, Y Yarden - Human Vaccines & …, 2015 - europepmc.org
Cancer progression depends on stepwise accumulation of oncogenic mutations and a
select group of growth factors essential for tumor growth, metastasis and angiogenesis …
select group of growth factors essential for tumor growth, metastasis and angiogenesis …